Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC) [Phase 1, Phase 2]

View source ↗

Summary

A Morpheus-CRC study evaluating immunotherapy-based treatment combinations in metastatic colorectal cancer has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Not specified

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-11-07